Connor, Clark & Lunn Investment Management Ltd.
Position in VKTX — Viking Therapeutics, Inc.
CIK 1596800
VANCOUVER, A1
Position in VKTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$16,794,154
-$1,457,089 QoQ
Shares Held
516,108
-0.5% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. VKTX ranks #9 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
384,681 | $20,280,382 |
All Filings in VKTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,794,154 | 516,108 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $18,251,243 | 518,796 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $14,301,602 | 544,201 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,851,250 | 447,217 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $14,429,987 | 597,515 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $15,098,933 | 375,222 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $10,025,075 | 158,349 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,638,201 | 49,768 | Shares | Sole | 2024-08-09 | |
| 2023-09-30 | $845,305 | 76,360 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,200,032 | 197,411 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,505,592 | 90,426 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $829,512 | 88,246 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $706,892 | 259,887 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $644,071 | 222,862 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $356,118 | 118,706 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $180,315 | 39,199 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $150,406 | 23,950 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $83,925 | 14,011 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||